RBC Capital Sticks to Its Hold Rating for CSL (CMXHF)
RBC Capital analyst Craig Wong-Pan maintained a Hold rating on CSL (CMXHF – Research Report) on January 29 and set a price target of A$286.00.
Resmed (RMD) Gets a Hold from RBC Capital
RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.